SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-060276
Filing Date
2023-11-07
Accepted
2023-11-07 16:16:24
Documents
62
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tyra-20230930.htm   iXBRL 10-Q 1739379
2 EX-10.1 tyra-ex10_1.htm EX-10.1 39293
3 EX-31.1 tyra-ex31_1.htm EX-31.1 18657
4 EX-31.2 tyra-ex31_2.htm EX-31.2 18850
5 EX-32.1 tyra-ex32_1.htm EX-32.1 10319
6 EX-32.2 tyra-ex32_2.htm EX-32.2 10282
  Complete submission text file 0000950170-23-060276.txt   6435231

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tyra-20230930_pre.xml EX-101.PRE 241277
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tyra-20230930_def.xml EX-101.DEF 125856
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tyra-20230930_lab.xml EX-101.LAB 333600
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tyra-20230930.xsd EX-101.SCH 42866
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tyra-20230930_cal.xml EX-101.CAL 31020
56 EXTRACTED XBRL INSTANCE DOCUMENT tyra-20230930_htm.xml XML 1181381
Mailing Address 2656 STATE STREET CARLSBAD CA 92008
Business Address 2656 STATE STREET CARLSBAD CA 92008 (619) 728-4760
Tyra Biosciences, Inc. (Filer) CIK: 0001863127 (see all company filings)

IRS No.: 831476348 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40800 | Film No.: 231384149
SIC: 2834 Pharmaceutical Preparations